Abstract
The recent debate about health care reform has focused largely on issues of equal access, cost containment, and delivery of primary care with some minor appreciation of the need for continued support for research and development. The central paradigm of this discussion is universal coverage and ways to finance it. Largely absent from consideration is the recognition that public health policies must drastically reduce the current disease-oriented treatment approach by encouraging significant changes in provider and consumer attitudes toward health promotion and health maintenance. Abundant evidence indicates that a health care system with a goal of promoting health and preventing illness will cost less than the present system, which basically operates to respond to the presence of illness with expensive diagnostic and therapeutic interventions. Consensus reports, like those from the US Surgeon General and National Research Council, clearly support the notion of preventive nutrition: that the most important choice people can make to influence their long-term health prospects is the choice of diet (1–3). Importantly, the modalities of this choice extend beyond a knowledgeable selection of food items and include nutrient enrichment, fortification, supplementation, and most recently, the potential of functional foods (4).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
US Surgeon General. Report on nutrition and health. Washington, DC: US Department of Health and Human Services, 1988.
National Research Council. Diet and health: implications for reducing chronic disease risk. Washington, DC: National Academy Press, 1989.
Health and Welfare Canada. Nutrition recommendations: the report of the Scientific Review Committee. Ottawa: Minister of Supply and Services, 1990.
Goldberg I. Functional foods: designer foods, pharmafoods, nutraceuticals. New York: Chapman & Hall, 1994.
National Research Council. Recommended dietary allowances. Washington, DC: National Academy Press, 1989.
US Department of Agriculture, Department of Health and Human Services. Nutrition and your health: Dietary guidelines for Americans. 3rd ed, 1990. [Home and Garden Bulletin No. 232]
US Department of Health and Human Services, National Cancer Institute, National Institutes of Health. Diet, nutrition and cancer prevention: a guide to food choices. Washington, DC: US Govermnent Printing Office, 1984. [NIH publication no. 85–2711]
Food and Nutrition Board, Institute of Medicine. How should the Recommended DietaryAllowances be revised? Washington, DC: National Academy Press, 1994.
National Center for Health Statistics. Healthy People 2000 Review, 1994. Hyattsville MD: Public Health Service, 1995. [DHHS Publication No. 95–125–61.]
US Public Health Service. Recommendation for the use of folic acid to reduce the number of cases of spina bifida and other neural tube defects. Morb Mortal Wkly Rep 1992; 41:RR-14.
Canadian Task Force on the Periodic Health Examination. 1994 update: 3. Primary and secondary prevention of neural tube defects. Can MedAssoc J 1994; 151:159–166.
Elwood M. Prevention of neural tube defects: clinical and public health policy. NZ Med J 1993; 106•517–518
Hennekens CH, Buring JE. Epidemiology in Medicine. Boston: Little, Brown, 1987.
Kune S, Kune GA, Watson LE Case-control study of dietary etiological factors: The Melbourne Colorectal Cancer Study. Nutr Cancer 1987; 9:21–42.
Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Summary of the second report of the National Cholesterol Education Program expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel II). JAMA 1993; 269:3015–3023.
Hodis HN, Mack WJ, LaBree L, Cashin-Hemphill L, Sevanian A, Johnson R, Azern SP. Serial coronary angiographic evidence that antioxidant vitamin intake reduces progress of coronary artery atherosclerosis. JAMA 1995; 273:1849–1854.
Nielson GJ. Technical report: analysis of costs associated with the clinical use of nutritional supplements. Columbus, OH: Abbott Laboratories, 1993.
Cassel CK, Brody JA. Demograph, epidemiology, and aging. In: Geriatric Medicine, 2nd ed. Cassel CK, Riesenberg DE, Sorensen LB, Walsh JA, eds. New York: Springer Verlag, 1990; 16–27.
National Center for Health Statistics. Monthly Vital Statistics Report 1988; 37:April 25.
Fries JF, Green LW, Levine S. Health promotion and the compression of morbidity. Lancet 1989; 4:481–483.
Havlick RJ, Feinleib M, eds. Proceedings of the conference on the decline in coronary heart disease mortality. Bethesda, MD: Public Health Service. [DHEW Publication No. (NIH). 1979:79–161].
Rose G. Strategy of prevention: lessons from cardiovascular disease. Br Med J 1981; 282:1847–1851.
Beaglehole R. Medical management and the decline in mortality from coronary heart disease. Br Med J 1986; 292:33–35.
Gomez-Marin 0, Folsom AR, Kottke TE, Wu SC, Jacobs DR Jr, Gillum RF, Edlavitch SA, Blackburn H. Improvement in long-term survival among patients hospitalized with acute myocardial infarction: 1970 to 1980. New Engl J Med 1987; 316:1353–1359.
Goldberg RJ, Gore JM, Alpert JS, Dalen JE. Recent changes in attack and survival among patients hospitalized with acute myocardial infarction (1975 through 1981). JAMA 1986; 255:2774–2779.
Keaney JF, Frei B. Antioxidant protection of low-density lipoprotein and its role in the prevention of atherosclerotic vascular disease. In: Natural Antioxidants in Human Health and Disease. Frei B, ed. San Diego: Academic Press, 1994; 303–352.
Ueland PM, Refsum H, Brattström L. Plasma homocysteine and cardiovascular disease. In: Atherosclerotic Cardiovascular Disease, Hemostasis, and Endothelial Function. Francis RB Jr, ed. New York: Marcel Dekker, 1992; 183–236.
Rose G. Sick individuals and sick populations. Int J Epidemiol 1985; 14:32–38.
Ballar JC, Smith EM. Progress against cancer. New Engl J Med 1986; 314:1226–1232.
Eddy DM. Screening for lung cancer. Ann Intern Med 1989; 111:232–237.
The Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study Group. The effect of vitamin E and betacarotene on the incidence of lung cancer and other cancers in male smokers. New Engl J Med 1994; 330:1029–1035.
Mayne ST, Janerich DT, Greenwald P, Chorost S, Tucci C, Zaman MB. Dietary beta carotene and lung cancer risk in U.S. nonsmokers. J Natl Cancer Inst 1994; 86:33–38.
Ziegler R. A review of epidemiologic evidence that carotenoids reduce the risk of cancer. J Nutr 1989; 119:116–122.
Block G. Vitamin C and cancer prevention: the epidemiologic evidence. Am J Clin Nutr 1991; 54:270S–282S.
Knekt P. Epidemiology of vitamin E: evidence for anticancer effects in humans. In: Vitamin E in Health and Disease Packer L Fuchs J. eds. New York: Marcel Dekker. 1993 • 513–527.
Optimal calcium intake. NIH Consensus Statement 1994. Jun 6–8; 12(4):1–31.
Klag MJ, Whelton PK, Whelton AA. Decline in U.S. stroke mortality: demographic trends and antihypertensive treatment. Stroke 1989; 20:14–21.
Kannel WB, Wolf PA. Epidemiology of cerebrovascular disease. In: Vascular Disease of the Central Nervous System. Russell RWR, ed. Edinburgh: Churchill Livingstone, 1983:1–24.
Bonita R, Beaglehole R. Does treatment of hypertension explain the decline in mortality from stroke? Br Med J 1986; 292:191,192.
Reed D, Yano K, Kagan A. Lipid and lipoproteins as predictors of coronary heart disease, stroke, and cancer in the Honolulu Heart Program. Am J Med 1986; 80:871–878.
Tanaka H, Hayashi M, Date C, Imai K, Asada M, Shoji H, Okazake K, Yamamoto H, Yoshikawa K, Shimada T, Lee SI. Epidemiologic studies of stroke in Shibata, a Japanese provincial city: preliminary report on risk factors for cerebral infarction. Stroke 1985; 16:773–780.
Snowden DA. Animal product consumption and mortality because of all causes combined, coronary heart disease, stroke, diabetes, and cancer in Seventh-Day Adventists. Am J Clin Nutr 1988; 48:739–748.
Selhub J, Jacques PF, Bostom AG, D’Agostino RB, Wilson PWF, Belanger AJ, O’Leary AH, Wolf PA, Schaefer EJ, Rosenberg IH. Association between plasma homocysteine concentrations and extracranial carotid-artery stenosis. New Engl J Med 1995; 332:286–291.
US Department of Health and Human Services, National Diabetes Data Group. National Institute of Health. Public Health Service Diabetes in America: Diabetes data compiled 1984. National Institute of Arthritis, Diabetes and Digestive and Kidney Diseases, 1985. [NIH Publ. No 85–14681.
Anderson RA. Chromium metabolism and its role in disease processes in man. Chem Physiol Biochem 1986; 4:31–41.
Paolisso G, Di Maro G, Galzerano D, Cacciapuotti F, Varricchio G, Varrichio M, D’onofrio F. Pharmacological doses of vitamin E and insulin action in elderly subjects. Am J Clin Nutr 1994; 59:1291–1296.
Cummings SR, Kelsey JL, Nevitt MC, O’Dowd KJ. Epidemiology of osteoporosis and osteoporotic fractures. Epidemiol Rev 1985; 7:178–208.
Dawson-Hughes B, Krall EA, Harris S. Risk factors for bone loss in healthy postmenopausal women. Osteoporosis Intl 1993; 3:S27–S31.
Chapuy MC, Arlot ME, Duboeuf F, Brun J, Crouzet B, Arnaud S, Delmas PD, Meunier, PJ. Vitamin D3 and calcium to prevent hip fractures in elderly women. New Engl J Med 1992; 327:1637–1642.
Heikinheimo RJ, Inkovaara JA, Harju EJ, Haavisto MV, Kaarela RH, Kataja JM, Hokko AM, Kolho LA, Rajala SA. Annual injection of vitamin D and fractures of aged bones. Calcif Tissue Int 1992; 51:105–110.
Aloia JF, Vaswani A, Yeh JK, Ross PL, Faster E, Dilmanian FA. Calcium supplementation with and without hormone replacement therapy to prevent postmenopausal bone loss. Ann Int Med 1994; 120:97–103.
Saltman PD, Strause LG. The role of trace minerals in osteoporosis. J Am Coll Nutr, 1993; 12:384–389.
Strause L, Saltman P, Smith KT, Bracker M, Andon MB. Spinal bone loss in postmenopausal women supplemented with calcium and trace minerals. J Nutr 1994; 124:1060–1064.
Nielsen FH. Studies on the relationship between boron and magnesium which possibly affects the formation and maintenance of bones. Magnesium Trace Elements, 1990; 9:61–69.
Blumberg JB. Vitamins. In: Diet, Nutrition, and Immunity. Forse RA, ed. Boca Raton, FL: CRC, 1994; 237–246.
Chandra RK. Effect of vitamin and trace-element supplementation on immune responses and infection in elderly subiects. Lancet 1992; 340:1124–1127.
Bogden JD, Bendich A, Kemp FW, Bruening KS, Skurnick JH, Denny T, Baker H, Louria DB. Daily micronutrient supplements enhance delayed hypersensitivity skin test responses in older people. Am J Clin Nutr 1994; 60:437–447.
Jacques PF, Chylack LT Jr, Taylor A. Relationships between natural antioxidants and cataract formation. In: Natural Antioxidants in Human Health and Disease. Frei B, ed. San Diego: Academic, 1994; 515–533.
Sperduto RD, Hu T–S, Milton RC, Zhao JL, Everett DF, Cheng Q–F, Blot WJ, Bing L, Taylor PR, Jun-Yao L, Guo W–D. The Linxian Cataract Studies: two nutrition intervention trials. Arch Ophthalmol 1993; 111:1246–1253.
West S, Vitale S, Hallfrisch J, Munoz B, Muller D, Bressler S, Bressler NM. Are antioxidants or supplements protective for age-related macular degeneration? Arch Ophthalmol 1994; 112:222–227.
Seddon JM, Ajani UA, Sperduto RD, Hiller R, Blair HN, Burton TC, Farber MD, Gragoudas ES, Haller J, Miller DT, Yannuzzi LA, Willett W. Dietary carotenoids, vitamins A, C, and E, and advanced age-related macular degeneration. JAMA 1994; 272:1413–1420.
Goodwin JS, Goodwin JM, Garry, PJ. Association between nutritional status and cognitive functioning in a healthy elderly population. JAMA 1983; 249:2917–2921.
Tucker DM, Penland JG, Sandstead HH, Milne DB, Heck DG, Klevay LM. Nutrition status and brain function in aging. Am J Clin Nutr 1990; 52:93–102.
Rose G. Sick individuals and sick populations. Int J Epidemiol 1985; 14:32–38.
Stehbens WE. The concept of cause in disease. J Chron Dis 1985; 38:947–950.
Doll R, Hill AB. Mortality in relation to smoking: ten years’ observations of British doctors. Br Med J 1964; 1:1399–1410.
Rose G. Incubation period of coronary heart disease. Br Med J 1982; 284:1600–1601.
Rimm EB, Stampfer MJ, Ascherio A, Giovannucci E, Colditz GA, Willett WC. Vitamin E consumption and the risk of coronary heart disease in men. New Engl J Med 1993; 328:1450–1456.
Jalial I, Fuller CJ, Huet BA. The effect of a-tocopherol supplementation on LDL oxidation. Arteriosclerosis Thromb Vasc Biol 1995; 15:190–198.
Gori G, Richter BS. Macroeconomics of disease prevention in the United States. Science 1978; 200:1124–1129.
Schneider EL, Guralnik JM. The aging of America: impact on health care costs. JAMA 1990; 263:2335–2340.
Fries JF. Aging, illness, and health policy: implication of the compression of morbidity. Perspect Biol Med 1988; 31:407–428.
Leaf A. Preventive medicine for our ailing health care system. JAMA 1993; 269:616–618.
Olshansky SJ, Carnes BA, Cassel C. In search of Methuselah: estimating the upper limits to human longevity. Science 1990; 250:634–639.
Fries JF. Reduction of the national morbidity. Gerontol Perspect 1987; 1:54–65.
Tarlov AR, Ware JE, Greenfield D, Nelson EC, Perin E, Zubkoff N. The Medical Outcomes Study: an application of methods for monitoring the results of medical care. JAMA 1989; 262:925–930.
Fries JF. Aging, natural death. and the compression of morbidity. New Engl J Med 1980; 303:130–136.
Fries JF, Crapo LM. Vitality and Aging. New York: Freeman, 1981.
Fries JF. The compression of morbidity: miscellaneous comments about a heme. Gerontologist 1984; 24:354–359.
Tornstam L. The quo vadis of gerontology: on the scientific paradigm of gerontology. Gerontologist 1992; 32:318–326.
Olshandsky SJ, Rudberg MA, Carnes BA, Cassell CK, Brody JA. Trading off longer life for worsening health: the expansion of morbidity hypothesis. JAging Health 1991; 3:194–216.
Guralnick JM, LaCroix AZ, Branch LG, Kasi SV, Wallace RB. Morbidity and disability in older persons in the years prior to death. Am J Public Health 1991; 81:443–447.
Rudberg MA, Cassel CK. Are death and disability in old age preventable? Fact Res Gerontol 1993; 7:191–201.
Multiple Risk Factor Intervention Trial Research Group. Coronary heart disease death, non-fatal acute myocardial infarction and other clinical outcomes in the multiple risk factor intervention trial. Am J Cardiol 1986;58:1–13.
Tsevat J, Weinstein MC, Williams LW, Tosteson AN, Goldman L. Expected gains in life expectancy from various coronary heart disease risk modifications. Circulation 1991; 83:1194–1201.
Fries JF, Tilton-Fries S, Parcell CL, Harrington H. Health risk changes with a low-cost individualized health promotion program: effects at up to 30 months. Am J Health Promotion 1992; 6:364–371.
Leigh JP, Richardson N, Beck R, Kerr C, Harrington H, Parcell CL, Fries JF. Randomized controlled study of a retiree health promotion program: the Bank of America study. Arch Intern Med 1992; 152:1201–1206.
Pelletier KR. A review and analysis of the health and cost-effective outcome studies of comprehensive health nromotion and disease nrevention program Am J Health Promotion 1991 • 5•311–313
Eisenberg DM, Kessler RC, Foster C, Norlack FE, Calkins DR, Delbanco TL. Unconventional medicine in the United States: prevalence, costs, and patterns of use. New Engl J Med 1993; 328:246–252.
National Academy of Sciences. Nutrition education in U.S. medical schools. Washington DC: National Academy Press, 1985.
Feldman EB. Networks for medical nutrition education―a review of the U.S. experience and future prospects. Am J Clin Nutr 1995; 62:512–517.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1997 Springer Science+Business Media New York
About this chapter
Cite this chapter
Blumberg, J.B. (1997). Public Health Implications of Preventive Nutrition. In: Bendich, A., Deckelbaum, R.J. (eds) Preventive Nutrition. Nutrition ◊ and ◊ Health. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-4757-6242-6_1
Download citation
DOI: https://doi.org/10.1007/978-1-4757-6242-6_1
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-4757-6244-0
Online ISBN: 978-1-4757-6242-6
eBook Packages: Springer Book Archive